ALPS Unit, LI/NIAID, National Institutes of Health, DHHS, Room 12C106, Building 10, 10 Center Dr, Bethesda, MD 20892-1899.
Pediatrics. 2013 Nov;132(5):e1440-4. doi: 10.1542/peds.2012-2748. Epub 2013 Oct 7.
Autoimmune lymphoproliferative syndrome (ALPS) is a rare inherited disorder of apoptosis, most commonly due to mutations in the FAS (TNFRSF6) gene. It presents with chronic lymphadenopathy, splenomegaly, and symptomatic multilineage cytopenias in an otherwise healthy child. Unfortunately, these clinical findings are also noted in other childhood lymphoproliferative conditions, such as leukemia, lymphoma, and hemophagocytic lymphohistiocytosis, which can confound the diagnosis. This report describes a 6-year-old girl with symptoms misdiagnosed as hemophagocytic lymphohistiocytosis and treated with chemotherapy before the recognition that her symptoms and laboratory values were consistent with a somatic FAS mutation leading to ALPS. This case should alert pediatricians to include ALPS in the differential diagnosis of a child with lymphadenopathy, splenomegaly, and cytopenias; obtain discriminating screening laboratory biomarkers, such as serum vitamin B-12 and ferritin levels; and, in the setting of a highly suspicious clinical scenario for ALPS, pursue testing for somatic FAS mutations when germ-line mutation testing is negative.
自身免疫性淋巴增生综合征(ALPS)是一种罕见的凋亡遗传疾病,最常见的原因是 FAS(TNFRSF6)基因突变。它表现为慢性淋巴结病、脾肿大和其他健康儿童的多谱系细胞减少症。不幸的是,这些临床发现也见于其他儿童淋巴增生性疾病,如白血病、淋巴瘤和噬血细胞性淋巴组织细胞增多症,这可能会混淆诊断。本报告描述了一名 6 岁女孩,其症状误诊为噬血细胞性淋巴组织细胞增多症,并在认识到她的症状和实验室值与导致 ALPS 的体细胞 FAS 突变一致之前接受了化疗。这个病例应该提醒儿科医生将 ALPS 纳入具有淋巴结病、脾肿大和细胞减少症的儿童的鉴别诊断中;获得有区别的筛选实验室生物标志物,如血清维生素 B-12 和铁蛋白水平;并且,在高度怀疑 ALPS 的临床情况下,当种系突变检测为阴性时,应进行体细胞 FAS 突变检测。